A Chinese company has bought Israeli biotech D-Pharm’s DP-VPA epilepsy drug, for use in China, Hong Kong and Macau. And it hasn’t even completed trials yet.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000650458&fid=1725
Epilepsy medication licensed to the Far East
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.